← Back to Search

Self-Management Survivorship Care for Lung and Colorectal Cancer

N/A

Waitlist Available

Led By Virginia Sun

Research Sponsored by City of Hope Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

History of stage I-III disease

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 8 months

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a self-management program for cancer survivors to see if it improves follow-up care, communication with doctors, and quality of life.

Who is the study for?

This trial is for stage I-III non-small cell lung or colorectal cancer survivors who finished treatment at least 4 months ago. Participants must understand English and be willing to consent to the study's requirements. Those unable to comply with the study as judged by the investigator cannot join.

What is being tested?

The trial examines a telehealth self-management program aimed at improving survivorship care for cancer survivors. It includes coaching on follow-up care, using tools like telemedicine, survivorship care plans, questionnaires, and quality-of-life assessments.

What are the potential side effects?

Since this trial focuses on survivorship care rather than medication or invasive treatments, traditional side effects are not expected. However, participants may experience stress or discomfort related to discussing their cancer experience.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My cancer was initially stage I, II, or III.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 8 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 8 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 8 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Care coordination

Oncologist/primary care providers (PCP) communication

PCP knowledge in survivorship care

+3 more

Other study objectives

Outcome Measure for facilitators

Overall reach (participation rate) with primary care providers (Arm I)

Percentage of primary care providers who received a clinical care plan (Arm I)

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (personalized care plan, telehealth sessions)Experimental Treatment4 Interventions

Patients receive a personalized care plan/resource manual. Patients also participate in 5 telehealth sessions with a nurse over 60 minutes each for 4 months (months 1-4) about self-management skills building, then 3 maintenance telehealth sessions with a nurse over 60 minutes each for 3 months (months 5-7) for additional self-management skills building support. A copy of patient's care plan is also sent to their PCP.

Group II: Arm II (ASCO care plan, telehealth sessions)Active Control3 Interventions

Patients receive an ASCO care plan. Patients also participate in 5 telehealth sessions with a nurse over 60 minutes each for 4 months (months 1-4) to answer questions on a handbook about life after cancer treatment, then 3 monthly telehealth sessions with a nurse over 60 minutes each for 3 months (months 5-7) to answer questions about the handbook. A copy of the ASCO care plan is also sent to their PCP.

0 / 1Eligibility criteria met